APO Research, Inc.

APO RESEARCH · REPORT

Life & Health Reinsurance

Selected research

Market Outlook & Growth Opportunities

Global Life & Health Reinsurance Market Outlook and Growth Opportunities 2026

Market perspective

The global Life & Health Reinsurance market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Life & Health Reinsurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Life & Health Reinsurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Life & Health Reinsurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Life & Health Reinsurance market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Life & Health Reinsurance market include Munich Re, Swiss Re, Hannover Re, SCOR SE, Lloyd’s, Berkshire Hathaway, Great-West Lifeco, RGA and China RE, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Life & Health Reinsurance market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Life & Health Reinsurance and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Life & Health Reinsurance revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Life & Health Reinsurance market.

Life & Health Reinsurance Segment by Company

Munich Re

Swiss Re

Hannover Re

SCOR SE

Lloyd’s

Berkshire Hathaway

Great-West Lifeco

RGA

China RE

Korean Re

PartnerRe

GIC Re

Mapfre

Alleghany

Everest Re

Axa

Canada Life Reinsurance

Fairfax

AXIS

CCR Re

Sompo

The Toa Reinsurance Company

Life & Health Reinsurance Segment by Type

Proportional Reinsurance

Non-proportional Reinsurance

Life & Health Reinsurance Segment by Application

Children

Adults

Senior Citizens

Life & Health Reinsurance Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Life & Health Reinsurance status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Life & Health Reinsurance key companies, revenue, market share, and recent developments.

3. To split the Life & Health Reinsurance breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Life & Health Reinsurance market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Life & Health Reinsurance significant trends, drivers, influence factors in global and regions.

6. To analyze Life & Health Reinsurance competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Life & Health Reinsurance market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Life & Health Reinsurance and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Life & Health Reinsurance.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Life & Health Reinsurance industry.

Chapter 3: Detailed analysis of Life & Health Reinsurance company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Life & Health Reinsurance in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Life & Health Reinsurance in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Life & Health Reinsurance Industry Trends Table 2. Life & Health Reinsurance Industry Drivers Table 3. Life & Health Reinsurance Industry Opportunities and Challenges Table 4. Life & Health Reinsurance Industry Restraints Table 5. Global Life & Health Reinsurance Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Life & Health Reinsurance Revenue Share by Company (2021-2026) Table 7. Global Life & Health Reinsurance Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Life & Health Reinsurance Key Company Manufacturing Base & Headquarters Table 9. Global Life & Health Reinsurance Company, Product Type & Application Table 10. Global Life & Health Reinsurance Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Life & Health Reinsurance by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Proportional Reinsurance Table 15. Significant Companies of Non-proportional Reinsurance Table 16. Global Life & Health Reinsurance Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Life & Health Reinsurance Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Life & Health Reinsurance Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Life & Health Reinsurance Sales Value Share by Type (2021-2026) Table 20. Global Life & Health Reinsurance Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Children Table 22. Significant Companies of Adults Table 23. Significant Companies of Senior Citizens Table 24. Global Life & Health Reinsurance Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Life & Health Reinsurance Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Life & Health Reinsurance Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Life & Health Reinsurance Sales Value Share by Application (2021-2026) Table 28. Global Life & Health Reinsurance Sales Value Share by Application (2027-2032) Table 29. Global Life & Health Reinsurance Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Life & Health Reinsurance Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Life & Health Reinsurance Sales Value Share by Region (2021-2026) Table 32. Global Life & Health Reinsurance Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Life & Health Reinsurance Sales Value Share by Region (2027-2032) Table 34. Global Life & Health Reinsurance Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Life & Health Reinsurance Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Life & Health Reinsurance Sales Value Market Share by Country (2021-2026) Table 37. Global Life & Health Reinsurance Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Life & Health Reinsurance Sales Value Market Share by Country (2027-2032) Table 39. Munich Re Company Information Table 40. Munich Re Business Overview Table 41. Munich Re Life & Health Reinsurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Munich Re Life & Health Reinsurance Product Portfolio Table 43. Munich Re Recent Development Table 44. Swiss Re Company Information Table 45. Swiss Re Business Overview Table 46. Swiss Re Life & Health Reinsurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Swiss Re Life & Health Reinsurance Product Portfolio Table 48. Swiss Re Recent Development Table 49. Hannover Re Company Information Table 50. Hannover Re Business Overview Table 51. Hannover Re Life & Health Reinsurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Hannover Re Life & Health Reinsurance Product Portfolio Table 53. Hannover Re Recent Development Table 54. SCOR SE Company Information Table 55. SCOR SE Business Overview Table 56. SCOR SE Life & Health Reinsurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. SCOR SE Life & Health Reinsurance Product Portfolio Table 58. SCOR SE Recent Development Table 59. Lloyd’s Company Information Table 60. Lloyd’s Business Overview Table 61. Lloyd’s Life & Health Reinsurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Lloyd’s Life & Health Reinsurance Product Portfolio Table 63. Lloyd’s Recent Development Table 64. Berkshire Hathaway Company Information Table 65. Berkshire Hathaway Business Overview Table 66. Berkshire Hathaway Life & Health Reinsurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Berkshire Hathaway Life & Health Reinsurance Product Portfolio Table 68. Berkshire Hathaway Recent Development Table 69. Great-West Lifeco Company Information Table 70. Great-West Lifeco Business Overview Table 71. Great-West Lifeco Life & Health Reinsurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Great-West Lifeco Life & Health Reinsurance Product Portfolio Table 73. Great-West Lifeco Recent Development Table 74. RGA Company Information Table 75. RGA Business Overview Table 76. RGA Life & Health Reinsurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. RGA Life & Health Reinsurance Product Portfolio Table 78. RGA Recent Development Table 79. China RE Company Information Table 80. China RE Business Overview Table 81. China RE Life & Health Reinsurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. China RE Life & Health Reinsurance Product Portfolio Table 83. China RE Recent Development Table 84. Korean Re Company Information Table 85. Korean Re Business Overview Table 86. Korean Re Life & Health Reinsurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Korean Re Life & Health Reinsurance Product Portfolio Table 88. Korean Re Recent Development Table 89. PartnerRe Company Information Table 90. PartnerRe Business Overview Table 91. PartnerRe Life & Health Reinsurance Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. PartnerRe Life & Health Reinsurance Product Portfolio Table 93. PartnerRe Recent Development Table 94. GIC Re Company Information Table 95. GIC Re Business Overview Table 96. GIC Re Life & Health Reinsurance Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. GIC Re Life & Health Reinsurance Product Portfolio Table 98. GIC Re Recent Development Table 99. Mapfre Company Information Table 100. Mapfre Business Overview Table 101. Mapfre Life & Health Reinsurance Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Mapfre Life & Health Reinsurance Product Portfolio Table 103. Mapfre Recent Development Table 104. Alleghany Company Information Table 105. Alleghany Business Overview Table 106. Alleghany Life & Health Reinsurance Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Alleghany Life & Health Reinsurance Product Portfolio Table 108. Alleghany Recent Development Table 109. Everest Re Company Information Table 110. Everest Re Business Overview Table 111. Everest Re Life & Health Reinsurance Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Everest Re Life & Health Reinsurance Product Portfolio Table 113. Everest Re Recent Development Table 114. Axa Company Information Table 115. Axa Business Overview Table 116. Axa Life & Health Reinsurance Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Axa Life & Health Reinsurance Product Portfolio Table 118. Axa Recent Development Table 119. Canada Life Reinsurance Company Information Table 120. Canada Life Reinsurance Business Overview Table 121. Canada Life Reinsurance Life & Health Reinsurance Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Canada Life Reinsurance Life & Health Reinsurance Product Portfolio Table 123. Canada Life Reinsurance Recent Development Table 124. Fairfax Company Information Table 125. Fairfax Business Overview Table 126. Fairfax Life & Health Reinsurance Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Fairfax Life & Health Reinsurance Product Portfolio Table 128. Fairfax Recent Development Table 129. AXIS Company Information Table 130. AXIS Business Overview Table 131. AXIS Life & Health Reinsurance Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. AXIS Life & Health Reinsurance Product Portfolio Table 133. AXIS Recent Development Table 134. CCR Re Company Information Table 135. CCR Re Business Overview Table 136. CCR Re Life & Health Reinsurance Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. CCR Re Life & Health Reinsurance Product Portfolio Table 138. CCR Re Recent Development Table 139. Sompo Company Information Table 140. Sompo Business Overview Table 141. Sompo Life & Health Reinsurance Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Sompo Life & Health Reinsurance Product Portfolio Table 143. Sompo Recent Development Table 144. The Toa Reinsurance Company Company Information Table 145. The Toa Reinsurance Company Business Overview Table 146. The Toa Reinsurance Company Life & Health Reinsurance Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. The Toa Reinsurance Company Life & Health Reinsurance Product Portfolio Table 148. The Toa Reinsurance Company Recent Development Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Life & Health Reinsurance Product Image Figure 2. Global Life & Health Reinsurance Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Life & Health Reinsurance Market Size (2021-2032) & (US$ Million) Figure 4. Global Life & Health Reinsurance Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Proportional Reinsurance Image Figure 8. Non-proportional Reinsurance Image Figure 9. Global Life & Health Reinsurance Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Life & Health Reinsurance Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Life & Health Reinsurance Sales Value Share by Type (2021-2032) Figure 12. Children Image Figure 13. Adults Image Figure 14. Senior Citizens Image Figure 15. Global Life & Health Reinsurance Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Life & Health Reinsurance Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Life & Health Reinsurance Sales Value Share by Application (2021-2032) Figure 18. Global Life & Health Reinsurance Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Life & Health Reinsurance Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Life & Health Reinsurance Sales Value (2021-2032) & (US$ Million) Figure 21. North America Life & Health Reinsurance Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Life & Health Reinsurance Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Life & Health Reinsurance Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Life & Health Reinsurance Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Life & Health Reinsurance Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Life & Health Reinsurance Sales Value (2021-2032) & (US$ Million) Figure 27. South America Life & Health Reinsurance Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Life & Health Reinsurance Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Life & Health Reinsurance Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Life & Health Reinsurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Proportional Reinsurance
  • Non-proportional Reinsurance
Applications
  • Children
  • Adults
  • Senior Citizens
Companies covered
  • Munich Re
  • Swiss Re
  • Hannover Re
  • SCOR SE
  • Lloyd’s
  • Berkshire Hathaway
  • Great-West Lifeco
  • RGA
  • China RE
  • Korean Re
  • PartnerRe
  • GIC Re
  • Mapfre
  • Alleghany
  • Everest Re
  • Axa
  • Canada Life Reinsurance
  • Fairfax
  • AXIS
  • CCR Re
  • Sompo
  • The Toa Reinsurance Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Life & Health Reinsurance Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Life & Health Reinsurance Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Life & Health Reinsurance Market Dynamics
  1. 2.1 Life & Health Reinsurance Industry Trends
  2. 2.2 Life & Health Reinsurance Industry Drivers
  3. 2.3 Life & Health Reinsurance Industry Opportunities and Challenges
  4. 2.4 Life & Health Reinsurance Industry Restraints
3 Life & Health Reinsurance Market by Company
  1. 3.1 Global Life & Health Reinsurance Company Revenue Ranking in 2025
  2. 3.2 Global Life & Health Reinsurance Revenue by Company (2021-2026)
  3. 3.3 Global Life & Health Reinsurance Company Ranking (2024-2026)
  4. 3.4 Global Life & Health Reinsurance Company Manufacturing Base and Headquarters
  5. 3.5 Global Life & Health Reinsurance Company Product Type and Application
  6. 3.6 Global Life & Health Reinsurance Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Life & Health Reinsurance Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Life & Health Reinsurance Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Life & Health Reinsurance Market by Type
  1. 4.1 Life & Health Reinsurance Type Introduction
  2. 4.1.1 Proportional Reinsurance
  3. 4.1.2 Non-proportional Reinsurance
  4. 4.2 Global Life & Health Reinsurance Sales Value by Type
  5. 4.2.1 Global Life & Health Reinsurance Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Life & Health Reinsurance Sales Value by Type (2021-2032)
  7. 4.2.3 Global Life & Health Reinsurance Sales Value Share by Type (2021-2032)
5 Life & Health Reinsurance Market by Application
  1. 5.1 Life & Health Reinsurance Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adults
  4. 5.1.3 Senior Citizens
  5. 5.2 Global Life & Health Reinsurance Sales Value by Application
  6. 5.2.1 Global Life & Health Reinsurance Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Life & Health Reinsurance Sales Value by Application (2021-2032)
  8. 5.2.3 Global Life & Health Reinsurance Sales Value Share by Application (2021-2032)
6 Life & Health Reinsurance Regional Value Analysis
  1. 6.1 Global Life & Health Reinsurance Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Life & Health Reinsurance Sales Value by Region (2021-2032)
  3. 6.2.1 Global Life & Health Reinsurance Sales Value by Region: 2021-2026
  4. 6.2.2 Global Life & Health Reinsurance Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Life & Health Reinsurance Sales Value (2021-2032)
  7. 6.3.2 North America Life & Health Reinsurance Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Life & Health Reinsurance Sales Value (2021-2032)
  10. 6.4.2 Europe Life & Health Reinsurance Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Life & Health Reinsurance Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Life & Health Reinsurance Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Life & Health Reinsurance Sales Value (2021-2032)
  16. 6.6.2 South America Life & Health Reinsurance Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Life & Health Reinsurance Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Life & Health Reinsurance Sales Value Share by Country, 2025 VS 2032
7 Life & Health Reinsurance Country-level Value Analysis
  1. 7.1 Global Life & Health Reinsurance Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Life & Health Reinsurance Sales Value by Country (2021-2032)
  3. 7.2.1 Global Life & Health Reinsurance Sales Value by Country (2021-2026)
  4. 7.2.2 Global Life & Health Reinsurance Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Munich Re
  2. 8.1.1 Munich Re Company Information
  3. 8.1.2 Munich Re Business Overview
  4. 8.1.3 Munich Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Munich Re Life & Health Reinsurance Product Portfolio
  6. 8.1.5 Munich Re Recent Developments
  7. 8.2 Swiss Re
  8. 8.2.1 Swiss Re Company Information
  9. 8.2.2 Swiss Re Business Overview
  10. 8.2.3 Swiss Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Swiss Re Life & Health Reinsurance Product Portfolio
  12. 8.2.5 Swiss Re Recent Developments
  13. 8.3 Hannover Re
  14. 8.3.1 Hannover Re Company Information
  15. 8.3.2 Hannover Re Business Overview
  16. 8.3.3 Hannover Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hannover Re Life & Health Reinsurance Product Portfolio
  18. 8.3.5 Hannover Re Recent Developments
  19. 8.4 SCOR SE
  20. 8.4.1 SCOR SE Company Information
  21. 8.4.2 SCOR SE Business Overview
  22. 8.4.3 SCOR SE Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SCOR SE Life & Health Reinsurance Product Portfolio
  24. 8.4.5 SCOR SE Recent Developments
  25. 8.5 Lloyd’s
  26. 8.5.1 Lloyd’s Company Information
  27. 8.5.2 Lloyd’s Business Overview
  28. 8.5.3 Lloyd’s Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lloyd’s Life & Health Reinsurance Product Portfolio
  30. 8.5.5 Lloyd’s Recent Developments
  31. 8.6 Berkshire Hathaway
  32. 8.6.1 Berkshire Hathaway Company Information
  33. 8.6.2 Berkshire Hathaway Business Overview
  34. 8.6.3 Berkshire Hathaway Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Berkshire Hathaway Life & Health Reinsurance Product Portfolio
  36. 8.6.5 Berkshire Hathaway Recent Developments
  37. 8.7 Great-West Lifeco
  38. 8.7.1 Great-West Lifeco Company Information
  39. 8.7.2 Great-West Lifeco Business Overview
  40. 8.7.3 Great-West Lifeco Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Great-West Lifeco Life & Health Reinsurance Product Portfolio
  42. 8.7.5 Great-West Lifeco Recent Developments
  43. 8.8 RGA
  44. 8.8.1 RGA Company Information
  45. 8.8.2 RGA Business Overview
  46. 8.8.3 RGA Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  47. 8.8.4 RGA Life & Health Reinsurance Product Portfolio
  48. 8.8.5 RGA Recent Developments
  49. 8.9 China RE
  50. 8.9.1 China RE Company Information
  51. 8.9.2 China RE Business Overview
  52. 8.9.3 China RE Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  53. 8.9.4 China RE Life & Health Reinsurance Product Portfolio
  54. 8.9.5 China RE Recent Developments
  55. 8.10 Korean Re
  56. 8.10.1 Korean Re Company Information
  57. 8.10.2 Korean Re Business Overview
  58. 8.10.3 Korean Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Korean Re Life & Health Reinsurance Product Portfolio
  60. 8.10.5 Korean Re Recent Developments
  61. 8.11 PartnerRe
  62. 8.11.1 PartnerRe Company Information
  63. 8.11.2 PartnerRe Business Overview
  64. 8.11.3 PartnerRe Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  65. 8.11.4 PartnerRe Life & Health Reinsurance Product Portfolio
  66. 8.11.5 PartnerRe Recent Developments
  67. 8.12 GIC Re
  68. 8.12.1 GIC Re Company Information
  69. 8.12.2 GIC Re Business Overview
  70. 8.12.3 GIC Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  71. 8.12.4 GIC Re Life & Health Reinsurance Product Portfolio
  72. 8.12.5 GIC Re Recent Developments
  73. 8.13 Mapfre
  74. 8.13.1 Mapfre Company Information
  75. 8.13.2 Mapfre Business Overview
  76. 8.13.3 Mapfre Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Mapfre Life & Health Reinsurance Product Portfolio
  78. 8.13.5 Mapfre Recent Developments
  79. 8.14 Alleghany
  80. 8.14.1 Alleghany Company Information
  81. 8.14.2 Alleghany Business Overview
  82. 8.14.3 Alleghany Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Alleghany Life & Health Reinsurance Product Portfolio
  84. 8.14.5 Alleghany Recent Developments
  85. 8.15 Everest Re
  86. 8.15.1 Everest Re Company Information
  87. 8.15.2 Everest Re Business Overview
  88. 8.15.3 Everest Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Everest Re Life & Health Reinsurance Product Portfolio
  90. 8.15.5 Everest Re Recent Developments
  91. 8.16 Axa
  92. 8.16.1 Axa Company Information
  93. 8.16.2 Axa Business Overview
  94. 8.16.3 Axa Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Axa Life & Health Reinsurance Product Portfolio
  96. 8.16.5 Axa Recent Developments
  97. 8.17 Canada Life Reinsurance
  98. 8.17.1 Canada Life Reinsurance Company Information
  99. 8.17.2 Canada Life Reinsurance Business Overview
  100. 8.17.3 Canada Life Reinsurance Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Canada Life Reinsurance Life & Health Reinsurance Product Portfolio
  102. 8.17.5 Canada Life Reinsurance Recent Developments
  103. 8.18 Fairfax
  104. 8.18.1 Fairfax Company Information
  105. 8.18.2 Fairfax Business Overview
  106. 8.18.3 Fairfax Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Fairfax Life & Health Reinsurance Product Portfolio
  108. 8.18.5 Fairfax Recent Developments
  109. 8.19 AXIS
  110. 8.19.1 AXIS Company Information
  111. 8.19.2 AXIS Business Overview
  112. 8.19.3 AXIS Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  113. 8.19.4 AXIS Life & Health Reinsurance Product Portfolio
  114. 8.19.5 AXIS Recent Developments
  115. 8.20 CCR Re
  116. 8.20.1 CCR Re Company Information
  117. 8.20.2 CCR Re Business Overview
  118. 8.20.3 CCR Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  119. 8.20.4 CCR Re Life & Health Reinsurance Product Portfolio
  120. 8.20.5 CCR Re Recent Developments
  121. 8.21 Sompo
  122. 8.21.1 Sompo Company Information
  123. 8.21.2 Sompo Business Overview
  124. 8.21.3 Sompo Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Sompo Life & Health Reinsurance Product Portfolio
  126. 8.21.5 Sompo Recent Developments
  127. 8.22 The Toa Reinsurance Company
  128. 8.22.1 The Toa Reinsurance Company Company Information
  129. 8.22.2 The Toa Reinsurance Company Business Overview
  130. 8.22.3 The Toa Reinsurance Company Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
  131. 8.22.4 The Toa Reinsurance Company Life & Health Reinsurance Product Portfolio
  132. 8.22.5 The Toa Reinsurance Company Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.